These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9114043)

  • 61. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids.
    Milburn JL; Hirose H; Lee YH; Nagasawa Y; Ogawa A; Ohneda M; BeltrandelRio H; Newgard CB; Johnson JH; Unger RH
    J Biol Chem; 1995 Jan; 270(3):1295-9. PubMed ID: 7836394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.
    Zhang B; Graziano MP; Doebber TW; Leibowitz MD; White-Carrington S; Szalkowski DM; Hey PJ; Wu M; Cullinan CA; Bailey P; Lollmann B; Frederich R; Flier JS; Strader CD; Smith RG
    J Biol Chem; 1996 Apr; 271(16):9455-9. PubMed ID: 8621615
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Change in lipid components in the adipose and liver tissues of regucalcin transgenic rats with increasing age: suppression of leptin and adiponectin gene expression.
    Yamaguchi M; Nakagawa T
    Int J Mol Med; 2007 Sep; 20(3):323-8. PubMed ID: 17671736
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of dietary fatty acids on insulin sensitivity and secretion.
    Manco M; Calvani M; Mingrone G
    Diabetes Obes Metab; 2004 Nov; 6(6):402-13. PubMed ID: 15479216
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endurance training increases FFA oxidation and reduces triacylglycerol utilization in contracting rat soleus.
    Dyck DJ; Miskovic D; Code L; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2000 May; 278(5):E778-85. PubMed ID: 10780932
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Basal lipolysis in epididymal fat cells from streptozotocin-induced diabetic rats.
    Tsujita T
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):47-53. PubMed ID: 16637229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Short-term leptin treatment increases fatty acids uptake and oxidation in muscle of high fat-fed rats.
    Todd MK; Yaspelkis BB; Turcotte LP
    Metabolism; 2005 Sep; 54(9):1218-24. PubMed ID: 16125533
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Leptin controls the fate of fatty acids in isolated rat white adipocytes.
    William WN; Ceddia RB; Curi R
    J Endocrinol; 2002 Dec; 175(3):735-44. PubMed ID: 12475384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition.
    Patanè G; Anello M; Piro S; Vigneri R; Purrello F; Rabuazzo AM
    Diabetes; 2002 Sep; 51(9):2749-56. PubMed ID: 12196468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.
    Dhalla AK; Santikul M; Chisholm JW; Belardinelli L; Reaven GM
    Diabetes Obes Metab; 2009 Feb; 11(2):95-101. PubMed ID: 18494808
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
    Reaven GM; Chang H; Hoffman BB
    Diabetes; 1988 Jan; 37(1):28-32. PubMed ID: 3275556
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipotoxicity in human pancreatic islets and the protective effect of metformin.
    Lupi R; Del Guerra S; Fierabracci V; Marselli L; Novelli M; Patanè G; Boggi U; Mosca F; Piro S; Del Prato S; Marchetti P
    Diabetes; 2002 Feb; 51 Suppl 1():S134-7. PubMed ID: 11815472
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
    Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
    BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dysregulation of the adipoinsular axis -- a mechanism for the pathogenesis of hyperleptinemia and adipogenic diabetes induced by fetal programming.
    Vickers MH; Reddy S; Ikenasio BA; Breier BH
    J Endocrinol; 2001 Aug; 170(2):323-32. PubMed ID: 11479129
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of metabolism of free fatty acid by isolated perfused livers from male and female rats.
    Soler-Argilaga C; Heimberg M
    J Lipid Res; 1976 Nov; 17(6):605-15. PubMed ID: 1032892
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats.
    Cai Y; Lydic TA; Turkette T; Reid GE; Olson LK
    Biochem Pharmacol; 2015 May; 95(1):46-57. PubMed ID: 25801003
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of habitual exercise and dietary restriction on intrahepatic and periepididymal fat accumulation in Zucker fatty rats.
    Kurosaka Y; Shiroya Y; Yamauchi H; Kaneko T; Okubo Y; Shibuya K; Minato K
    BMC Res Notes; 2015 Apr; 8():121. PubMed ID: 25885415
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
    Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
    Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models.
    Tsumura Y; Tsushima Y; Tamura A; Hasebe M; Kanou M; Kato H; Kobayashi T
    PLoS One; 2017; 12(2):e0172252. PubMed ID: 28207836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.